Dr. Apar Kishor Ganti is a physician-scientist, who completed his medical training and a residency in Clinical Pharmacology in Pune, India. He subsequently completed an Internal Medicine residency, a Medical Oncology fellowship and a Master’s Program in Clinical and Translational Research in the United States. Dr. Ganti is the Associate Director of Clinical Research at the UNMC Fred and Pamela Buffett Cancer Center. In addition, he is a member of the Respiratory Committee of the Alliance for Clinical Trials in Oncology. He is the Chair of the Small Cell Lung Cancer Committee of the National Comprehensive Cancer Network and a member of the VA Precision Oncology Program Advisory Committee and the VA Clinical Science Research & Development Centralized Data Monitoring Committee. Dr. Ganti’s research interests are focused on development of novel treatment approaches for patients who are not candidates for standard therapies. His laboratory is focused on evaluating new pathways in head and neck and lung cancer and identifying novel prognostic and predictive biomarkers for these malignancies. He has significant mentoring experience, having mentored medical students, residents and fellows and junior faculty in research projects that have been either presented at national or international meetings and/or published in peer reviewed journals.